Cargando…

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study

The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive™ 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifidobacterium longum DSMZ 32946,...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzydło-Radomańska, Barbara, Prozorow-Król, Beata, Cichoż-Lach, Halina, Majsiak, Emilia, Bierła, Joanna B., Kosikowski, Wojciech, Szczerbiński, Mariusz, Gantzel, Jesper, Cukrowska, Bożena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400954/
https://www.ncbi.nlm.nih.gov/pubmed/32635661
http://dx.doi.org/10.3390/nu12071999
_version_ 1783566476786008064
author Skrzydło-Radomańska, Barbara
Prozorow-Król, Beata
Cichoż-Lach, Halina
Majsiak, Emilia
Bierła, Joanna B.
Kosikowski, Wojciech
Szczerbiński, Mariusz
Gantzel, Jesper
Cukrowska, Bożena
author_facet Skrzydło-Radomańska, Barbara
Prozorow-Król, Beata
Cichoż-Lach, Halina
Majsiak, Emilia
Bierła, Joanna B.
Kosikowski, Wojciech
Szczerbiński, Mariusz
Gantzel, Jesper
Cukrowska, Bożena
author_sort Skrzydło-Radomańska, Barbara
collection PubMed
description The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive™ 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifidobacterium longum DSMZ 32946, Bifidobacterium bifidum DSMZ 32403 and fructooligosaccharides in adult patients with diarrhea-dominant IBS (IBS-D). The study included eighty patients with moderate and severe IBS-D who were randomized to receive synbiotics or placebo for eight weeks. Finally, a total of sixty-eight patients finished the study. The primary endpoints included the assessment of the symptoms’ severity with IBS symptom severity scale (IBS-SSS), an improvement of IBS global symptoms with Global Improvement Scale (IBS-GIS) and adequate relief of symptoms after four and eight weeks of therapy. Secondary endpoints, which were collected by telephone interviewers three times a week included the assessment of individual IBS symptoms and adverse events. Synbiotic treatment in comparison to placebo significantly improved IBS-GIS (p = 0.043), and IBS-SSS score inducing a decrease in the total IBS-SSS (p = 0.042) and in domain-specific scores related to flatulence (p = 0.028) and bowel habit (p = 0.028) after four and eight weeks. Patients treated with synbiotics reported in weekly observations a significant amelioration in a feeling of incomplete bowel movements, flatulence, pain, stool pressure and diarrheal stools compared to those receiving placebo. There were no differences in adverse events between both groups. Concluding, the multi-strain synbiotic preparation was associated with a significant improvement in symptoms in IBS-D patients and was well-tolerated. These results suggest that the use of synbiotics offers a benefit for IBS-D patients. [Clinicaltrials.gov NCT04206410 registered 20 December 2019].
format Online
Article
Text
id pubmed-7400954
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74009542020-08-07 The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study Skrzydło-Radomańska, Barbara Prozorow-Król, Beata Cichoż-Lach, Halina Majsiak, Emilia Bierła, Joanna B. Kosikowski, Wojciech Szczerbiński, Mariusz Gantzel, Jesper Cukrowska, Bożena Nutrients Article The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive™ 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifidobacterium longum DSMZ 32946, Bifidobacterium bifidum DSMZ 32403 and fructooligosaccharides in adult patients with diarrhea-dominant IBS (IBS-D). The study included eighty patients with moderate and severe IBS-D who were randomized to receive synbiotics or placebo for eight weeks. Finally, a total of sixty-eight patients finished the study. The primary endpoints included the assessment of the symptoms’ severity with IBS symptom severity scale (IBS-SSS), an improvement of IBS global symptoms with Global Improvement Scale (IBS-GIS) and adequate relief of symptoms after four and eight weeks of therapy. Secondary endpoints, which were collected by telephone interviewers three times a week included the assessment of individual IBS symptoms and adverse events. Synbiotic treatment in comparison to placebo significantly improved IBS-GIS (p = 0.043), and IBS-SSS score inducing a decrease in the total IBS-SSS (p = 0.042) and in domain-specific scores related to flatulence (p = 0.028) and bowel habit (p = 0.028) after four and eight weeks. Patients treated with synbiotics reported in weekly observations a significant amelioration in a feeling of incomplete bowel movements, flatulence, pain, stool pressure and diarrheal stools compared to those receiving placebo. There were no differences in adverse events between both groups. Concluding, the multi-strain synbiotic preparation was associated with a significant improvement in symptoms in IBS-D patients and was well-tolerated. These results suggest that the use of synbiotics offers a benefit for IBS-D patients. [Clinicaltrials.gov NCT04206410 registered 20 December 2019]. MDPI 2020-07-05 /pmc/articles/PMC7400954/ /pubmed/32635661 http://dx.doi.org/10.3390/nu12071999 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Skrzydło-Radomańska, Barbara
Prozorow-Król, Beata
Cichoż-Lach, Halina
Majsiak, Emilia
Bierła, Joanna B.
Kosikowski, Wojciech
Szczerbiński, Mariusz
Gantzel, Jesper
Cukrowska, Bożena
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title_full The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title_fullStr The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title_full_unstemmed The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title_short The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome—A Randomized Double-Blind, Placebo-Controlled Study
title_sort effectiveness of synbiotic preparation containing lactobacillus and bifidobacterium probiotic strains and short chain fructooligosaccharides in patients with diarrhea predominant irritable bowel syndrome—a randomized double-blind, placebo-controlled study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400954/
https://www.ncbi.nlm.nih.gov/pubmed/32635661
http://dx.doi.org/10.3390/nu12071999
work_keys_str_mv AT skrzydłoradomanskabarbara theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT prozorowkrolbeata theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT cichozlachhalina theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT majsiakemilia theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT bierłajoannab theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT kosikowskiwojciech theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT szczerbinskimariusz theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT gantzeljesper theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT cukrowskabozena theeffectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT skrzydłoradomanskabarbara effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT prozorowkrolbeata effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT cichozlachhalina effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT majsiakemilia effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT bierłajoannab effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT kosikowskiwojciech effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT szczerbinskimariusz effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT gantzeljesper effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy
AT cukrowskabozena effectivenessofsynbioticpreparationcontaininglactobacillusandbifidobacteriumprobioticstrainsandshortchainfructooligosaccharidesinpatientswithdiarrheapredominantirritablebowelsyndromearandomizeddoubleblindplacebocontrolledstudy